Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Non-interventional Study to Investigate the Disease Characteristics of Adult Patients With Long Chain Fatty Acid Oxidation Disorders (FAOD)

NCT04482049 is registered in ClinicalTrials.gov with Reneo Pharma Ltd as lead sponsor.

NCT NCT04482049
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04482049 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Non-interventional Study to Investigate the Disease Characteristics of Adult Patients With Long Chain Fatty Acid Oxidation Disorders (FAOD)
Lead sponsor
Reneo Pharma Ltd
Phase
Observational
Overall status
Completed
Start date
January 15, 2021
Completion date
May 4, 2022
Enrollment
61 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

fatty acid oxidation disorder